Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Higher incidence of toxicity has been reported in patients treated with combinations in up to 30% of the cases and grade III toxicity has been reported in 6-19% of these cases [7,18-23]
Investors and industry participants would likely benefit from monitoring adoption rates and consumer retention, rather than assuming the current momentum will persist indefinitely
Kern, E
10.1159/000531606 70 SakouhiM.MatmourD.BelakhdarK.KraroubiA
US$ 26.99
US$ 28.22
US$ 25.32
US$ 20.34
US$ 27.31
US$ 25.54
US$ 22.27
US$ 24.02
US$ 21.53
US$ 22.67
US$ 20.21
US$ 26.59
